Publications by authors named "Helen Parfrey"

Claim this Profile
S
Sex-specific genetic effects on susceptibility to idiopathic pulmonary fibrosis.
Olivia C Leavy, Anne F Goemans, Tamara Hernandez-Beeftink, Amy D Stockwell, Richard J Allen, Helen Parfrey

ERJ Open Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial.
Megan Jones, Anthony Cahn, Nazia Chaudhuri, Allan B Clark, Ian Forrest, Helen Parfrey

BMJ Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study of Idiopathic Pulmonary Fibrosis susceptibility using clinically-curated European-ancestry datasets.
Daniel Chin, Tamara Hernandez-Beeftink, Lauren Donoghue, Beatriz Guillen-Uio, Olivia C Leavy, Helen Parfrey

medRxiv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis.
William Whalen, Kristin Berger, John S Kim, Will Simmons, Shwu-Fan Ma, Helen Parfrey

Am J Respir Crit Care Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide SNP-sex interaction analysis of susceptibility to idiopathic pulmonary fibrosis.
Olivia C Leavy, Anne F Goemans, Amy D Stockwell, Richard J Allen, Beatriz Guillen-Guio, Helen Parfrey

medRxiv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosis.
Beatriz Guillen-Guio, Megan L Paynton, Richard J Allen, Daniel P W Chin, Lauren J Donoghue, Helen Parfrey

ERJ Open Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association study of human leukocyte antigen (HLA) variants and idiopathic pulmonary fibrosis.
Beatriz Guillen-Guio, Megan L Paynton, Richard J Allen, Daniel P W Chin, Lauren J Donoghue, Helen Parfrey

medRxiv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCSK6 and Survival in Idiopathic Pulmonary Fibrosis.
Justin M Oldham, Richard J Allen, Jose M Lorenzo-Salazar, Philip L Molyneaux, Shwu-Fan Ma, Helen Parfrey

Am J Respir Crit Care Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants.
Anna L Peljto, Rachel Z Blumhagen, Avram D Walts, Jonathan Cardwell, Julia Powers, Helen Parfrey

Am J Respir Crit Care Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial.
Toby M Maher, Veronica A Tudor, Peter Saunders, Michael A Gibbons, Sophie V Fletcher, Helen Parfrey

Lancet Respir Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of forehead and finger oximetry sensors during the six minute walk test.
Lucy Robertson, Rachel Lowry, Karl Sylvester, Helen Parfrey, Beverley Moseley

Chron Respir Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The hidden costs of living with systemic sclerosis-associated interstitial lung disease.
Helen Parfrey

Respirology· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitization of the UPR by loss of PPP1R15A promotes fibrosis and senescence in IPF.
Susan Monkley, Catherine Overed-Sayer, Helen Parfrey, Doris Rassl, Damian Crowther

Sci Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Reported Experiences and Delays During the Diagnostic Pathway for Pulmonary Fibrosis: A Multinational European Survey.
Iris G van der Sar, Steve Jones, Deborah L Clarke, Francesco Bonella, Jean Michel Fourrier, Helen Parfrey

Front Med (Lausanne)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiopathic pulmonary fibrosis in the UK: analysis of the British Thoracic Society electronic registry between 2013 and 2019.
Lisa G Spencer, Maria Loughenbury, Nazia Chaudhuri, Monica Spiteri, Helen Parfrey

ERJ Open Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study.
Thomas M Drake, Annemarie B Docherty, Ewen M Harrison, Jennifer K Quint, Huzaifa Adamali, Helen Parfrey

Am J Respir Crit Care Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial.
Andrew M Wilson, Allan B Clark, Tony Cahn, Edwin R Chilvers, William Fraser, Helen Parfrey

JAMA· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects.
Catherine Overed-Sayer, Elena Miranda, Rebecca Dunmore, Elena Liarte Marin, Lorea Beloki, Helen Parfrey

Thorax· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying causation in hypersensitivity pneumonitis: a British perspective.
Christopher Michael Barber, P Sherwood Burge, Jo R Feary, Helen Parfrey, Elizabeth A Renzoni

BMJ Open Respir Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.
Richard J Allen, Beatriz Guillen-Guio, Justin M Oldham, Shwu-Fan Ma, Amy Dressen, Helen Parfrey

Am J Respir Crit Care Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of mycophenolate mofetil and azathioprine for the treatment of chronic hypersensitivity pneumonitis-A single-centre experience.
Christine A Fiddler, Nicky Simler, Muhunthan Thillai, Helen Parfrey

Clin Respir J· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.
Camille Moore, Rachel Z Blumhagen, Ivana V Yang, Avram Walts, Julie Powers, Helen Parfrey

Am J Respir Crit Care Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice.
Sophie V Fletcher, Mark G Jones, Elizabeth A Renzoni, Helen Parfrey, Rachel K Hoyles

ERJ Open Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis